Magnetic Core–Shell Nanocapsules with Dual‐Targeting Capabilities and Co‐Delivery of Multiple Drugs to Treat Brain Gliomas
暂无分享,去创建一个
Jen-Hung Fang | Y. Chen | San-Yuan Chen | Shang‐Hsiu Hu | San-Yuan Chen | You-Yin Chen | Shang-Hsiu Hu | Yen-Ho Lai | Tsung-Lang Chiu | Yen-Ho Lai | T. Chiu | Jen‐Hung Fang
[1] H. Friedman,et al. Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice. , 1983, Cancer research.
[2] María J. Vicent,et al. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.
[3] D. Gewirtz,et al. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. , 1994, Molecular pharmacology.
[4] B. Zlokovic. Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means , 1998 .
[5] K. Ulbrich,et al. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. , 2009, Biomaterials.
[6] H. Brem,et al. Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU , 1996 .
[7] S. Sahoo,et al. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. , 2011, Molecular pharmaceutics.
[8] H. von Briesen,et al. Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays , 2006, Journal of drug targeting.
[9] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[10] G. Lesinski,et al. Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines , 2009, Molecular Cancer Therapeutics.
[11] Z. Qian,et al. The mechanism of Fe(2+)-initiated lipid peroxidation in liposomes: the dual function of ferrous ions, the roles of the pre-existing lipid peroxides and the lipid peroxyl radical. , 2000, The Biochemical journal.
[12] W. Pardridge,et al. Human blood-brain barrier transferrin receptor. , 1987, Metabolism: clinical and experimental.
[13] L. Mayer,et al. Optimizing combination chemotherapy by controlling drug ratios. , 2007, Molecular interventions.
[14] J. Dobson,et al. Magnetic nanoparticles for gene and drug delivery , 2008, International journal of nanomedicine.
[15] Ping Wang,et al. Aptamer‐Mediated Magnetic and Gold‐Coated Magnetic Nanoparticles as Detection Assay for Prion Protein Assessment , 2007, Biotechnology progress.
[16] D. Strickland,et al. Diverse roles for the LDL receptor family , 2002, Trends in Endocrinology & Metabolism.
[17] Hao Zeng,et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.
[18] Wenjin Xu,et al. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy. , 2012, Nanoscale.
[19] Y. Oh,et al. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[20] F. Campbell,et al. Role of glutathione S‐transferase P1, P‐glycoprotein and multidrug resistance‐associated protein 1 in acquired doxorubicin resistance , 2001, International journal of cancer.
[21] T. Yamashima,et al. In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. , 1995, Biochemical pharmacology.
[22] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[23] J. Schellens,et al. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. , 2006, Trends in pharmacological sciences.
[24] R. MacGillivray,et al. Ligand-induced conformational change in transferrins: crystal structure of the open form of the N-terminal half-molecule of human transferrin. , 1998, Biochemistry.
[25] Y. Chen,et al. Surfactant‐Free, Lipo‐Polymersomes Stabilized by Iron Oxide Nanoparticles/Polymer Interlayer for Synergistically Targeted and Magnetically Guided Gene Delivery , 2014, Advanced healthcare materials.
[26] S. Siegel,et al. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. , 1976, Cancer research.
[27] P. Poma,et al. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. , 2005, Cancer letters.
[28] V. Vergaro,et al. Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[29] W. Geldenhuys,et al. Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers , 2011, Journal of drug targeting.
[30] Po-Jung Chen,et al. Core‐Shell Nanocapsules Stabilized by Single‐Component Polymer and Nanoparticles for Magneto‐Chemotherapy/Hyperthermia with Multiple Drugs , 2012, Advanced materials.
[31] Jiguang Liu,et al. pH triggered injectable amphiphilic hydrogel containing doxorubicin and paclitaxel. , 2011, International journal of pharmaceutics.
[32] J. Gergely,et al. Zero-length crosslinking procedure with the use of active esters. , 1990, Analytical biochemistry.
[33] Yifeng Pan,et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. , 2012, International journal of pharmaceutics.
[34] Linlin Li,et al. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.
[35] Chandana Mohanty,et al. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. , 2012, Drug discovery today.
[36] R J Leatherbarrow,et al. Kinetics of protein-protein interactions at the surface of an optical biosensor. , 1995, Analytical biochemistry.
[37] A. Attia,et al. Advanced Materials for Co‐Delivery of Drugs and Genes in Cancer Therapy , 2012, Advanced healthcare materials.
[38] R. Béliveau,et al. Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2 , 2008, Journal of neurochemistry.
[39] P. Singal,et al. Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.
[40] Jin Chang,et al. PLGA/polymeric liposome for targeted drug and gene co-delivery. , 2010, Biomaterials.
[41] M. Mahmoudi,et al. Graphene: promises, facts, opportunities, and challenges in nanomedicine. , 2013, Chemical reviews.
[42] M. Tomayko,et al. Determination of subcutaneous tumor size in athymic (nude) mice , 2004, Cancer Chemotherapy and Pharmacology.
[43] K. Arnold,et al. The action of hypochlorous acid on phosphatidylcholine liposomes in dependence on the content of double bonds. Stoichiometry and NMR analysis. , 1995, Chemistry and physics of lipids.